arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ASSEMBLY BIOSCIENCES, INC.

ASMB
$20.00 ▲ +0.21 (+1.06%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
20 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Bearish
auto_awesome

Analytical Summary

ASSEMBLY BIOSCIENCES, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $224.2M
Dividend Yield —
Revenue Growth 153.5% ↘
Op. Margin -16.8% ↗
ROIC -5.9% ↗
FCF / Share $-3.67 ↗
Trailing P/E —
Price / Book 1.5x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$72.30M
↑ +153.5% —
Net Income Profit after all expenses
$-6.12M
↑ +84.8% —
Operating Margin Operating profit as % of sales
-16.8%
↑ +89.5% 11th
FCF / Share Free cash flow per share
$-3.67
↑ +56.9% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
11
Returns ↑
40
Cash Quality ↑
97

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 20 years · 71 quarters